![Yekaterina Chudnovsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yekaterina Chudnovsky
Directeur/Membre du Conseil chez
ELICIO THERAPEUTICS, INC.
Fortune : 38 M $ au 30/06/2026
Profil
Yekaterina Chudnovsky currently holds multiple positions including Chairman at Gi Research Foundation since 2023, Independent Director at Immix Biopharma, Inc. since 2023, Independent Director at Elicio Therapeutics, Inc. since 2022, and Director roles at Elicio Therapeutics, Inc. (United States), xCures, Inc., and GKCC LLC.
Education history includes undergraduate studies at Northwestern University and graduate studies at DePaul University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/05/2026 | 3 241 076 ( 4,55% ) | 33 M $ | 30/06/2026 | |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies 8,36% | 02/01/2026 | 500 003 ( 8,36% ) | 5 M $ | 30/06/2026 |
| 09/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Yekaterina Chudnovsky
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/10/2022 |
| IMMIX BIOPHARMA, INC. | Directeur/Membre du Conseil | 22/08/2023 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Directeur/Membre du Conseil | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence methodology and platform solutions | Directeur/Membre du Conseil | - |
Gkcc LLC
 Gkcc LLC Investment ManagersFinance GKCC invests in companies located in the United States. The firm focuses on companies across a broad range of sectors and industries. It participates in early stage transactions. | Directeur/Membre du Conseil | - |
Formation de Yekaterina Chudnovsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DePaul University
 DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence methodology and platform solutions | Technology Services |
Immix Biopharma, Inc.
 Immix Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cancer patients | Health Technology |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
Gkcc LLC
Gkcc LLC Investment ManagersFinance GKCC invests in companies located in the United States. The firm focuses on companies across a broad range of sectors and industries. It participates in early stage transactions. | Finance |
Choisissez Zonebourse 
